IRIS
LOPALCO, GIUSEPPE
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 6.390
EU - Europa 1.203
AS - Asia 558
Continente sconosciuto - Info sul continente non disponibili 7
SA - Sud America 3
AF - Africa 2
OC - Oceania 1
Totale 8.164
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 6.384
SE - Svezia 414
CN - Cina 361
IT - Italia 232
FR - Francia 219
SG - Singapore 135
DE - Germania 104
GB - Regno Unito 80
FI - Finlandia 62
BE - Belgio 27
VN - Vietnam 22
IN - India 18
CZ - Repubblica Ceca 15
UA - Ucraina 12
IE - Irlanda 11
IR - Iran 9
ES - Italia 7
EU - Europa 7
CA - Canada 5
TR - Turchia 4
AT - Austria 3
HR - Croazia 3
ID - Indonesia 3
JP - Giappone 3
RO - Romania 3
BR - Brasile 2
PT - Portogallo 2
AL - Albania 1
AR - Argentina 1
AU - Australia 1
BG - Bulgaria 1
CH - Svizzera 1
DO - Repubblica Dominicana 1
EG - Egitto 1
HK - Hong Kong 1
HU - Ungheria 1
IS - Islanda 1
LV - Lettonia 1
MN - Mongolia 1
NL - Olanda 1
NO - Norvegia 1
SI - Slovenia 1
TW - Taiwan 1
ZA - Sudafrica 1
Totale 8.164
Salva come PNG Salva come JPEG
Città #
Fairfield 1.056
Woodbridge 675
Houston 630
Chandler 545
Ashburn 513
Seattle 430
Ann Arbor 381
Cambridge 371
Nyköping 351
Wilmington 316
Lawrence 121
Roxbury 115
Singapore 107
Beijing 103
Jacksonville 84
Bari 81
Des Moines 75
Nanjing 74
New York 66
Inglewood 64
Princeton 56
San Diego 44
Shenyang 31
Dearborn 28
Paris 28
Brussels 27
Santa Clara 27
Munich 26
Dong Ket 21
London 20
Nanchang 20
Los Angeles 19
Brooklyn 16
Jiaxing 16
Boardman 14
Redwood City 14
Guangzhou 13
Hebei 13
Pune 13
Tianjin 12
Changsha 11
Dublin 11
San Mateo 11
Brno 10
Helsinki 10
Shanghai 10
Milan 8
San Francisco 8
Ardabil 7
Hounslow 7
Kilburn 7
Brindisi 6
Giovinazzo 6
Hefei 6
Augusta 5
Indiana 5
Jinan 5
Falls Church 4
Leawood 4
Pamplona 4
Prescot 4
Toronto 4
Washington 4
Boston 3
Cerignola 3
Detroit 3
Florence 3
Hangzhou 3
Modugno 3
Norwalk 3
Olomouc 3
Ostwald 3
Padova 3
Simi Valley 3
Taizhou 3
Taranto 3
Vienna 3
Wiesbaden 3
Wuhan 3
Avegno 2
Bitonto 2
Castellamonte 2
Chifeng 2
Chiswick 2
Chongqing 2
Clifton 2
Islington 2
Massa 2
Monmouth Junction 2
Málaga 2
Nagold 2
New Bedfont 2
Ningbo 2
Nürnberg 2
Terlizzi 2
Verdellino 2
Zagreb 2
Zhengzhou 2
Zogno 2
Acton 1
Totale 6.862
Salva come PNG Salva come JPEG
Nome #
Safety of Long-Term Biologic Therapy in Rheumatologic Patients With a Previously Resolved Hepatitis B Viral Infection 138
Efficacy and safety profile of anti-interleukin-1 treatment in Behçet’s disease: a multicenter retrospective study 130
Sarcopenia in Patients with Rheumatic Diseases: Prevalence and Associated Risk Factors 124
Cumulative retention rate of adalimumab in patients with Behçet's disease-related uveitis: a four-year follow-up study 119
Correlation between serum amyloid-A and serum levels of proinflammatory cytokines in patients with Behçet's disease 119
Basic characteristics of adults with periodic fever, aphthous stomatitis, pharyngitis, and adenopathy syndrome in comparison with the typical pediatric expression of disease 116
Autoimmunity and autoinflammation as the yin and yang of idiopathic recurrent acute pericarditis 113
Retinal vessels thrombosis as onset manifestation of systemic sclerosis: 3 clinical cases 109
Refractory knee giant cell tumor of the synovial membrane treated with intra-articular injection of Infliximab: A case series and review of the literature 107
Auditory involvement in Behcet’s disease: relationship with demographic, clinical, and therapeutic characteristics 107
Unveiling the Efficacy, Safety, and Tolerability of Anti-Interleukin-1 Treatment in Monogenic and Multifactorial Autoinflammatory Diseases 107
Comparative efficacy between adalimumab and infliximab in the treatment of non-infectious intermediate uveitis, posterior uveitis, and panuveitis: a retrospective observational study of 107 patients 106
A Bayesian mixed treatment comparison of efficacy of biologics and small molecules in early rheumatoid arthritis 106
Interleukin (IL)-1 inhibition with anakinra and canakinumab in Behçet's disease-related uveitis: a multicenter retrospective observational study 104
Ten-Year Retention Rate of Infliximab in Patients with Behçet's Disease-Related Uveitis 104
Different switching rate of anti-TNF-α drugs in monotherapy and in combination with methotrexate in a cohort of rheumatoid arthritis patients in the real life 103
Interleukin-1 as a common denominator from autoinflammatory to autoimmune disorders: Premises, perils, and perspectives 103
Management of Small Vessel Vasculitides 102
Mucocutaneous Involvement in Behçet's Disease: How Systemic Treatment Has Changed in the Last Decades and Future Perspectives 102
PFAPA syndrome and Behçet’s disease: a comparison of two medical entities based on the clinical interviews performed by three different specialists 100
Effectiveness and tuberculosis-related safety profile of interleukin-1 blocking agents in the management of Behçet's disease 99
A false occult hepatitis B virus infection developed in a patient with psoriatic arthritis under infliximab and methotrexate therapy 98
Tumor necrosis factor receptor-associated periodic syndrome managed with the couple canakinumab-alendronate 97
Efficacy and safety of adalimumab in Behçet's disease-related uveitis: a multicenter retrospective observational study. 96
Paradoxical mucocutaneous flare in a case of Behçet’s disease treated with tocilizumab 96
Key facts and hot spots on tumor necrosis factor receptor-associated periodic syndrome 96
Certolizumab Pegol treatment in Behcet's disease with different organ involvement: A multicenter retrospective observational study 95
Serum amyloid-A in Behçet's disease 94
Proinflammatory cytokines and antiskin autoantibodies in patients with inherited epidermolysis bullosa 94
Untangling the web of systemic autoinflammatory diseases 92
Efficacy of adalimumab and infliximab in recalcitrant retinal vasculitis inadequately responsive to other immunomodulatory therapies 90
AB0836 Drug retention rate of the first tnf inhibitor in radiographic and non radiographic axial spondyloarthritis: data from a multicenter study 90
Relapsing Polychondritis: an Update on Pathogenesis, Clinical Features, Diagnostic Tools, and Therapeutic Perspectives 88
Different roles of TNF inhibitors in acute anterior uveitis associated with ankylosing spondylitis: state of the art 87
AB0065 Possible Interplay Between Serum Amyloid-A and Pro-Inflammatory Cytokines Into the Pathogenesis of Behçet's Disease 87
null 86
A comprehensive comparison between pediatric and adult patients with periodic fever, aphthous stomatitis, pharyngitis, and cervical adenopathy (PFAPA) syndrome 86
Systemic Steroid Sparing Effect of Intravitreal Dexamethasone Implant in Chronic Noninfectious Uveitic Macular Edema 85
Long-term retention rate of anakinra in adult onset Still’s disease and predictive factors for treatment response 85
Lipids and atherogenic indices fluctuation in rheumatoid arthritis patients on long-term tocilizumab treatment 84
AB0041 Serum Amyloid A Stimulates The Induction of Inflammatory Mediators in Monocytes from Behçet's Disease Patients: A Proof of Concept Study 84
null 82
null 81
AB0452 Changes in Lipoproteins Associated with Tocilizumab Treatment Do not Influence the Atherogenic Index of Plasma of Rheumatoid Arthritis Patients: Table 1 81
Splenic Infarction as Only Manifestation of Antiphospholipid Syndrome in a Patient With Rheumatoid Arthritis 80
null 80
The protean ocular involvement in monogenic autoinflammatory diseases: state of the art 80
Longterm clinical outcomes in 420 patients with psoriatic arthritis taking anti-tumor necrosis factor drugs in real-world settings 78
Pain Processing and Vegetative Dysfunction in Fibromyalgia: A Study by Sympathetic Skin Response and Laser Evoked Potentials 77
IL-6 blockade in the management of non-infectious uveitis 76
null 75
Safety profile of the interleukin-1 inhibitors anakinra and canakinumab in real-life clinical practice: a nationwide multicenter retrospective observational study 74
SAT0212 Pericardial Effusion Related To Systemic Sclerosis: A Possible Contribution of The Serum Levels of Adipokines and Interleukines 74
THU0153 The effect of 5-years b-dmards treatment on different 10-years cardiovascular risk scores applied in rheumatoid arthritispatients 74
null 72
null 72
Long-term retention rates of adalimumab and infliximab in non-infectious intermediate, posterior, and panuveitis 72
Critical regulation of Th17 cell differentiation by serum amyloid-A signalling in Behcet's disease 71
AB0369 Adult-onset still’s disease treatment predictors at 1-year follow-up in a single rheumatologic centre experience 71
SAT0216 Chest Ultrasound Signs of Interstitial Lung Disease in Systemic Sclerosis Patients: A Comparison between High Resolution Chest Computed Tomography Findings 71
null 71
null 70
Behçet's syndrome in Italy: a detailed retrospective analysis of 396 cases seen in 3 tertiary referral clinics 70
Biological therapies for the treatment of Behçet’s disease-related uveitis beyond TNF-alpha blockade: a narrative review 69
FRI0110 Methotrexate monotherapy in real life: a drug survival analysis. comparison between very early arthritis and early arthritis cohorts 69
AB0245 PREDICTORS OF BIOLOGIC THERAPY DISCONTINUATION IN RHEUMATOID ARTHRITIS PATIENTS AFTER REMISSION ACHIEVEMENT: A MONOCENTRIC OBSERVATIONAL STUDY FROM BIOLOGIC APULIAN REGISTRY (BIOPURE) 68
The role of biosimilars in uveitis: Long-term real-world outcomes of the switch from original to biosimilar TNF-alpha inhibitors 68
Safety profile of biologic agents for Behçet's disease in a multicenter observational cohort study 66
Predictors of sustained clinical response in patients with Behçet’s disease-related uveitis treated with infliximab and adalimumab 65
Long-term safety of anti-TNF agents on the liver of patients with spondyloarthritis and potential occult hepatitis B viral infection: an observational multicentre study 63
null 62
null 62
Anakinra for corticosteroid-dependent and colchicine-resistant pericarditis: The IRAP (International Registry of Anakinra for Pericarditis) study 61
OP0129 Drug survival on anti-tnf-alpha in psoriatic arthritis patients with axial involvement and analysis of predictors 60
THU0168 Relationships between body fat composition assessed with bioelectrical impedance analysis, serum adipokines and disease activity in patients with rheumatoid arthritis 60
Putative role of serum amyloid-A and proinflammatory cytokines as biomarkers for behcet's disease 59
null 59
Influence of baseline modified Rheumatic Disease Comorbidity Index (mRDCI) on drug survival and effectiveness of biological treatment in patients affected with Rheumatoid arthritis, Spondyloarthritis and Psoriatic arthritis in real-world settings 58
Epidemiological profile of non-infectious uveitis from the rheumatologist's perspective: a survey from two tertiary referral centres in Italy 57
SAT0380 FIBROMYALGIA IS THE STRONGEST NEGATIVE PREDICTOR FOR THE ACHIEVEMENT OF EITHER REMISSION AND MINIMAL DISEASE ACTIVITY IN NAIVE PSORIATIC ARTHRITIS PATIENTS STARTING BIOLOGIC DRUGS 56
improvement of refractory dysphagia in patients with idiopathic inflammatory myopathies receveing immunoglubulin intravenous therapy 53
Different drug survival of first line tumour necrosis factor inhibitors in radiographic and non-radiographic axial spondyloarthritis: a multicentre retrospective survey 48
Improvement of Refractory Dysphagia in Patients with Idiopathic Inflammatory Myopathies Receveing Immunoglobulin Intravenous Therapy 47
Influence of changes in cholesterol levels and disease activity on the 10 years cardiovascular risk estimated with different algorithms in rheumatoid arthritis patients 46
The autoinflammatory side of recurrent pericarditis: Enlightening the pathogenesis for a more rational treatment 46
Development and Implementation of the AIDA International Registry for Patients with Non-Infectious Scleritis 45
Effectiveness and safety profile of anakinra in a HLA-B27 positive patient with multiple sclerosis-associated uveitis 44
null 43
Efficacy and Safety of Intravenous Immunoglobulin Treatment in Refractory Behcet's Disease with Different Organ Involvement: A Case Series 41
null 41
null 41
Real-world effectiveness of apremilast in multirefractory mucosal involvement of Behçet's disease 41
Tomographic regression of pulmonary rheumatoid nodules under baricitinib therapy 39
Intravitreal Dexamethasone Implant as an Adjunct Weapon for Severe and Refractory Uveitis in Behçet's Disease 38
Prompt Clinical Response to Secukinumab in Patients with Axial Spondyloarthritis: Real Life Observational Data from Three Italian Referral Centers 37
null 36
null 35
Immunogenicity of BNT162b2 mRNA SARS-CoV-2 vaccine in patients with psoriatic arthritis on TNF inhibitors 35
null 34
Effectiveness of TNF-α blockade in the treatment of refractory non-infectious scleritis: a multicentre study 34
Totale 7.666
Salva come PNG Salva come JPEG
Categoria #
all - tutte 40.875
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 40.875
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20202.051 0 0 49 169 266 233 256 309 342 157 182 88
2020/20211.476 84 140 110 59 249 139 129 127 118 138 96 87
2021/2022952 72 39 20 37 39 81 63 51 70 79 118 283
2022/20231.486 211 189 122 116 113 234 34 190 196 12 48 21
2023/2024533 39 101 25 42 48 127 18 28 6 14 13 72
2024/2025265 66 36 163 0 0 0 0 0 0 0 0 0
Totale 8.752